期刊文献+

半边莲生物碱缓解肾性高血压大鼠的血管重塑 被引量:10

Chinensis lour alkaloids alleviates vascular remodeling in renal hypertensive rats
下载PDF
导出
摘要 目的:探讨半边莲生物碱对肾性高血压大鼠主动脉血管重塑的影响。方法:制备两肾一夹(2K1C)肾性高血压大鼠模型,灌服半边莲生物碱或卡托普利8周,用放射免疫技术测定血浆肾素活性(plasma rennin activity,PRA)。用Weigert法染色并测量腹主动脉中膜厚度及中膜截面积等血管重塑形态学参数。分别用Masson三色法和免疫组化方法测腹主动脉总胶原蛋白含量和Ⅰ型胶原蛋白含量。结果:高血压大鼠与假手术组相比PRA明显升高(P<0.05),使用半边莲生物碱后PRA显著降低(P<0.05);卡托普利对PRA无明显影响。高血压大鼠中膜厚度、中膜厚度/血管内径、中膜面积和腹主动脉胶原含量与假手术组相比明显升高(P<0.05);半边莲和卡托普利均可使高血压组大鼠上述指标显著降低(P<0.05)。结论:肾性高血压大鼠存在血管重塑现象,半边莲生物碱能抑制胶原的表达、降低肾素活性,对缓解血管重塑有一定作用。 AIM: To investigate the effect of lobelia chinensis lour alkaloids (LCLAs) on vascular remodeling in renal hypertension. METHODS : The Glodblatt renovascular hypertension model was induced in rats by two-kidney one clip method. The renin activity (PRA) in plasma was determined by radioimmunoassay 8 weeks after the treatments with LCLAs or catoprill. The parameters of vascular remodeling, including media thickness ( MT), luminal internal diameter (LD), ratio of MT/LD and ratio of media cross-sectional area to lumen area (MSCA/LA) were measured through the Weigert staining photos of the abdominal aorta. Expressions of collagen and collagen I were measured respectively by the methods of Masson staining and immunohistochemistry. RESULTS: The PRA was significantly increased in hypertensive rats compared with the sham rats (P 〈0. 05). PRA was significantly reduced in LCLAs group compared to control group. No inhibitory effect on PRA was observed in captopril group. The MT, the ratio of MT/LD, MSCA and the expression of collagen on abdominal aorta were significantly increased in hypertensive rats compared with the sham rats ( P 〈 0. 05 ). LCLAs and captopril reduced these parameters raised in hypertensive rats (P 〈 0. 05 ). CONCLUSION: The vascular remodeling occurs in renal hypertensive rats. LCLA inhibits the synthesis of the collagen and reduces PRA, which may alleviate the vascular remodeling in hypertensive rats.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第6期1074-1077,共4页 Chinese Journal of Pathophysiology
基金 教育部高等学校博士学科点专项科研基金资助项目(No39730210) 山东省自然科学基金资助项目(NoQ2004C03)
关键词 半边莲属 胶原 高血压 肾性 血管重建 Lobelia Collagen Hypertension, renal Vascular remodeling
  • 相关文献

参考文献12

  • 1Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension [ J]. J Am Coil Cardiol, 2004, 43( 12 Suppl S) : 13 -24.
  • 2Kett MM, Denton KM, Boesen El, et al. Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing [ J ]. Am J Hypertens, 2004, 17(2) : 161 - 166.
  • 3王婧婧,范秀珍,刘尚明,魏欣冰,任冬梅,陈融,李莉,胡维诚.半边莲生物碱抑制内皮素诱导的大鼠主动脉平滑肌细胞增殖[J].中国动脉硬化杂志,2006,14(2):107-110. 被引量:7
  • 4Sigmon DH, Beierwaltes WH. Endothelium derived constricting factor in renovascular hypertension [ J]. Hypertension, 1995, 25(4 Pt 2) :803 -808.
  • 5Porteri E, Rizzoni D, Castellano M, et al. Structural changes of small resistance arteries in spontaneously hypertensive rats after treatment with various doses of lacidipine [J]. J Hypertens, 1997,15(6) :619 -625.
  • 6Mulvany MJ. Small artery remodeling in hypertension [J]. Curt Hypert Rep, 2002,4(1) :49 -55.
  • 7Gao DF, Niu XL, Hao GH, et al. Rosiglitazone inhibits angiotensin Ⅱ - induced CTGF expression in vascular smooth muscle cells - role of PPAR - gamma in vascular fibrosis. [ J ]. Biochem Pharmacol, 2007, 73 (2) : 185 - 197.
  • 8Miner EC, Miller WL. A look between the cardiomyocytes: The extracellular matrix in heart failure [ J ]. Mayo Clin Proc, 2006, 81 ( 1 ) :71 - 76.
  • 9Motte S, McEntee K, Naeije R. Endothelin receptor antagonists [J]. Pharmacol Ther, 2006, 110 (3) :386 - 414.
  • 10Perez del Villar C, Garcia Alonso CJ, Feldstein CA, et al. Role of endothelin in the pathogenesis of hypertension [J]. Mayo Clin Proc, 2005, 80( 1 ):84 -96.

二级参考文献19

  • 1范秀珍 ,胡维诚 .清热解毒类中药抗动脉粥样硬化作用机制的研究进展[J].中国动脉硬化杂志,2004,12(2):246-248. 被引量:26
  • 2Ducancel F.The sarafotoxins [ J ].Toxicon,2002,40 (11):1541-1545.
  • 3Hou YZ,Yang J,Zhao GR,et al.Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin Ⅱ[J].Eur J Pharmacol,2004,499(1-2):85-90.
  • 4Hafizi S,Allen SP,Goodwin AT,et al.Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ETA receptor and is co-mitogenic with growth factors[J].Atherosclerosis,1999,146(2):351-359.
  • 5Piacentini L,Gray M,Honbo NY,et al.Endothelin-1stimulates cardiac fibroblasts proliferation through activation of protein kinase C[J].J Mol Cell Cardiol,2000,32(4):565-576.
  • 6Shimoda LA,Sylvester JT,Booth GM,et al.Inhibition of voltage-gated K (+) currents by endothelin-1 in human pulmonary arterial myocytes[J].Am J Physiol,2001,281(5):L1115-L1122.
  • 7Xu Y,Sandirasegarane L,Gopalkrishnan V.Protein kinase C inhibitors enhance endothelin-1 and attenuate vasopressin and angiotensin Ⅱ evoked [ Ca^2+]i elevation in rat cardiomyocytes[J].Br J Pharmacol,1993,108(1):6-8.
  • 8Cheng FY,Marcelo G,Kazanietz.Divergence and complexities in DAG signaling:looking beyond PKC[J].Trends Pharmacol Sci,2003,24(11):602-608.
  • 9Mercedeh FV,Nils G,Christina M,et al.Distinct signaling pathways mediate cardiomyocyte phospholipase D stimulation by endothelin-1 and thromhin[J].J Mol Cell Cardiol,2002,34(4):441-453.
  • 10Visakorpi T.Proliferative activity determined by DNA flow cytometry and proliferative cell nuclear antigen immmunohistochemisty as a prognostic factor in prostatic carcinoma1 [ J ].J Pathol,1992,24(1):43-51.

共引文献10

同被引文献232

引证文献10

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部